Azilsartan Suppresses Osteoclastogenesis and Ameliorates Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species Production and Activating Nrf2 SignalingBin Pan, Dengwei He, Kainan Ni et al.|Frontiers in Pharmacology|2021Cited by 21
MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP1Bin Pan, Dengwei He, Jiawei Gao et al.|Cell Death Discovery|2022Cited by 20